Patrick Veit-Haibach, MD
- Deputy Chief / PMD (UHN sites)
- Division Head, Abdominal
Patrick Veit-Haibach is a dual-certified Radiologist and Nuclear Medicine Physician currently serving as the Director of the PET/MR program and Division Head Abdominal Imaging at the Joint Department Medical Imaging (JDMI), Toronto, Canada. He is Associate Professor of Radiology and Nuclear Medicine at the Department Medical Imaging at UoT. He completed his training in radiology and nuclear medicine in Germany and in Switzerland. Before joining the JDMI in 2017, he served as the head of the PET/CT-MRI section at the University Hospital Zurich, Switzerland.
His research interests focus on multi-modality molecular imaging strategies, particularly combined PET/MRI and PET/CT, perfusion- and hypoxia-imaging. Current projects involve clinical and preclinical molecular imaging research in esophago-gastric cancer, breast cancer, HCC, sarcoma, ENT cancer and lymphoma as well as technical evaluations in hybrid imaging.
- Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal Cancer
No abstract
- Prognostic Value of [18F]-FDG PET/CT Radiomics Combined with Sarcopenia Status among Patients with Advanced Gastroesophageal Cancer
No abstract
- Prognostic value of PET/CT and MR-based baseline radiomics among patients with non-metastatic nasopharyngeal carcinoma
No abstract
- 18F-DCFPyL PET/CT in advanced high-grade epithelial ovarian cancer: A prospective pilot study
No abstract
- Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up
No abstract
- Impact of Sites of Metastatic Dissemination on Survival in Advanced Gastroesophageal Adenocarcinoma
No abstract
- Diagnostic performance of [<sup>18</sup>F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis
No abstract
- Impact of 18F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer
No abstract
- Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis
No abstract
- Combined 18 F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer
No abstract
- The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis
No abstract
- Reproducibility of Standardized Uptake Values Including Volume Metrics Between TOF-PET-MR and TOF-PET-CT
No abstract
- Preoperative and Postoperative Approaches to Gastroesophageal Cancer: What is All the Fuss About
No abstract
- The clinical consequences of functional adrenal uptake in the absence of cross-sectional mass on FDG-PET/CT in oncology patients
No abstract
- Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis
No abstract
- The association between lesion tracer uptake on 68Ga-DOTATATE PET with morphological response to 177Lu-DOTATATE therapy in patients with progressive metastatic neuroendocrine tumors
No abstract
- 68Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement
No abstract
- Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer
No abstract
- 18F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center
No abstract
- A Path to Qualification of PET/MRI Scanners for Multicenter Brain Imaging Studies: Evaluation of MRI-Based Attenuation Correction Methods Using a Patient Phantom
No abstract
- Neuroendocrine Tumors: Imaging Perspective
No abstract
- Pitfalls on PET/MRI
No abstract
- Deep learning for whole-body medical image generation
No abstract
- A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation: A Pilot Study on a Novel Biomarker
No abstract
- Detection of clinically significant prostate cancer with 18F-DCFPyL PET/multiparametric MR
No abstract
- Canadian Urological Association best practice report: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and PET/magnetic resonance (MR) in prostate cancer
No abstract
- Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with 177Lu-DOTATATE
No abstract
- CT perfusion in peripheral arterial disease-hemodynamic differences before and after revascularisation
No abstract
- How to Design AI-Driven Clinical Trials in Nuclear Medicine
No abstract
- Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma
No abstract